Myokardia Inc (MYOK) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Myokardia Inc   (NASDAQ: MYOK)


Myokardia Inc's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Myokardia Inc's ROI in the third quarter of 2020?
Myokardia Inc recorded a cumulative net loss of $-277 million during 12 months ending in the third quarter of 2020, resulting in a negative return on investment (ROI) of -40.41%.

Within the Healthcare sector 464 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 0 to 3702.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM 35.64 % 13.72 % 5.34 % 52.01 % 66.4 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 983 955 396 408 455
Return On Investment (TTM) -40.41 % -60.37 % -67 % -53.66 % -46.13 %
MYOK's Overall Ranking # 3702 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 23.89 % 20.11 % -10.51 % 1.86 % 3.86 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -277 -334 -309 -276 -233

MYOK Company Profile >> Back to MYOK Roi Comparisons >> See Annual MYOK Return On Investment



Return On Investment MYOK's Ranking
Within: No.
Industry # 190
Sector # 465
Overall # 3702

Return On Investment Statistics
High Average Low
-2.09 %
-29.56 %
-67 %
(Dec 31 2016)   (Mar 31 2020)







Financial Statements
Myokardia Inc's III. Quarter Investments $ 983 Millions MYOK's Balance sheet
Myokardia Inc's III. Quarter Income $ -85 Millions Quarterly MYOK's Income Statement
MYOK's Income by Division See MYOK's Income by Division


MYOK Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 408 371 242 168 95
Y / Y Investment Growth 10.15 % 53.17 % 43.74 % 77.92 % -
Net Income in Millions -276 -68 -46 -13 -23
Y / Y Net Income Growth - - - - -
Annual Return On Investment -67.67 % -18.27 % -18.99 % -7.81 % -24.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MYOK's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MYOK's Competitors
Subscribers only: Roi for Myokardia Inc's Suppliers
Subscribers only: Return On Investment for MYOK's Customers

Other Ratios
MYOK's Roa MYOK's Inventory Turnover Ratio MYOK's Growth Rates MYOK's Dividend Statistics
MYOK's Profitability Ratios MYOK's Asset Turnover Ratio MYOK's Dividend Growth
MYOK's Roe MYOK's Valuation Ratios MYOK's Financial Strength Ratios MYOK's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI

Date modified: 2026-08-29T17:33:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.